WeVote
Log In

Bill

Bill

SB 1525

Relating to prior authorization for prescription drug benefits related to the treatment of neurodegenerative diseases.

89th Legislature (2025) Introduced by Carol Alvarado and 1 co-sponsor

SB 1525 would limit prior authorization requirements for neurodegenerative disease medications in Texas insurance plans to accelerate patient access to time-sensitive treatments.

Referred to Insurance
#health--otherdiseases&medicalconditions(i0383) #insurance--health&accident(i0422) #medicine&prescriptiondrugs(s7338)
0
WeVote Research Nonpartisan
Bill Summary · SB 1525

Legislative bill overview

SB 1525 would establish prior authorization requirements and limitations for prescription drug benefits specifically related to neurodegenerative disease treatments in Texas. The bill aims to streamline insurance approval processes for medications used to treat conditions like ALS, Parkinson's disease, and similar progressive neurological disorders. It has just begun the legislative process and is currently under review by the Insurance Committee.

Why is this important

Neurodegenerative diseases are progressive conditions where treatment delays can result in irreversible deterioration. Prior authorization—the requirement that insurers pre-approve medications before patients receive them—can cause dangerous delays in accessing time-sensitive treatments. This bill addresses a practical healthcare access issue affecting a vulnerable patient population with limited treatment windows.

Potential points of contention

  • Insurance industry concerns: Insurers may argue that blanket restrictions on prior authorization undermine cost controls and incentivize unnecessary prescriptions
  • Scope definition: Disagreement over which drugs and diseases qualify as "neurodegenerative" could affect how broadly the bill applies
  • Implementation costs: Healthcare providers and insurers may dispute administrative burdens and whether expedited review processes require additional resources or staffing

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.